Zanuso, Valentina
Nash, Tamsin
Casolino, Raffaella
Armstrong, Gregory
Pallise, Ona
Milne, Jen
Braconi, Chiara
Funding for this research was provided by:
COST action (Euro Cholangio Net, Euro Cholangio Net)
CRUK-Scotland Cancer Centre (100006)
Chief Scientist Office (TCS/21/25)
Article History
Received: 22 January 2024
Accepted: 17 April 2024
First Online: 16 May 2024
Declarations
:
: Competing Interests: CB received honoraria as speaker (Astrazeneca, Incyte, Servier) and consultant (Incyte, Servier, Boehringer Ingelheim, Astrazeneca), received research funds (Avacta, Medannex, Servier) and her spouse is an employee of Astrazeneca. VZ, TN, RC, GA, OP and JM have no conflict of interest.
: This study was approved by the ethical Caldicott committee for NHS Greater Glasgow & Clyde on 7/12/2021 (Demographics and Clinical Characteristics of Patients with Biliary Tract Cancer in Scotland), and was given the approval for clinical audit and publication. No identifiable information are present in this manuscript as per application. Informed consent was not obtained as per Sect. 60 of the Health and Social Care Act 2001, given this is a retrospective study and does not contain identifiable information.
: Not applicable.